These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30315488)

  • 21. Testing the convergent validity of the contingent valuation and travel cost methods in valuing the benefits of health care.
    Clarke PM
    Health Econ; 2002 Mar; 11(2):117-27. PubMed ID: 11921310
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Willingness to pay and the sensitivity of willingness to pay for interdisciplinary musculoskeletal clinics: a contingent valuation study in Quebec, Canada.
    Poder TG; He J
    Int J Health Econ Manag; 2016 Dec; 16(4):337-361. PubMed ID: 27878690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness to pay for QALY: perspectives and contexts in Japan.
    Igarashi A; Goto R; Yoneyama-Hirozane M
    J Med Econ; 2019 Oct; 22(10):1041-1046. PubMed ID: 31262236
    [No Abstract]   [Full Text] [Related]  

  • 24. An empirical note on willingness to pay and starting-point bias.
    Stålhammar NO
    Med Decis Making; 1996; 16(3):242-7. PubMed ID: 8818122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of Willingness to Pay: Does Time and Treatment Allocation in a Randomized Controlled Trial Influence Willingness to Pay?
    van der Pol M; Watson V; Boyers D
    Med Decis Making; 2024 Jul; 44(5):470-480. PubMed ID: 38738541
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Willingness of Infertile Couples to Pay for In Vitro Fertilization Treatment in the Integrated Human Reproduction Section of the Escola Paulista de Medicina, São Paulo Federal University.
    Lima SB; Antoniassi MP; Zylbersztejn DS; Fraietta R; Bertolla RP; Ferraz MB
    Value Health Reg Issues; 2020 Dec; 23():55-60. PubMed ID: 32841901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of 'reference goods' in contingent valuation: should we help respondents to 'construct' their willingness to pay?
    Smith RD
    Health Econ; 2007 Dec; 16(12):1319-32. PubMed ID: 17328037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contingent Valuation: A Pilot Study for Eliciting Willingness to Pay for a Reduction in Mortality From Vaccine-Preventable Illnesses for Children and Adults in Bangladesh.
    Odihi D; De Broucker G; Hasan Z; Ahmed S; Constenla D; Uddin J; Patenaude B
    Value Health Reg Issues; 2021 May; 24():67-76. PubMed ID: 33508753
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The reliability and validity of willingness to pay surveys for reproductive health pricing decisions in developing countries.
    Foreit JR; Foreit KG
    Health Policy; 2003 Jan; 63(1):37-47. PubMed ID: 12468116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The value of informal care--a further investigation of the feasibility of contingent valuation in informal caregivers.
    de Meijer C; Brouwer W; Koopmanschap M; van den Berg B; van Exel J
    Health Econ; 2010 Jul; 19(7):755-71. PubMed ID: 19548326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigating the Willingness to Pay for a Contributory National Health Insurance Scheme in Saudi Arabia: A Cross-sectional Stated Preference Approach.
    Al-Hanawi MK; Vaidya K; Alsharqi O; Onwujekwe O
    Appl Health Econ Health Policy; 2018 Apr; 16(2):259-271. PubMed ID: 29307076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Framing the willingness-to-pay question: impact on response patterns and mean willingness to pay.
    Gyrd-Hansen D; Jensen ML; Kjaer T
    Health Econ; 2014 May; 23(5):550-63. PubMed ID: 23696155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Empirical implications of response acquiescence in discrete-choice contingent valuation.
    Yeung RY; Smith RD; Ho LM; Johnston JM; Leung GM
    Health Econ; 2006 Oct; 15(10):1077-89. PubMed ID: 16518835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Willingness to pay for drug abuse treatment: results from a contingent valuation study in Taiwan.
    Tang CH; Liu JT; Chang CW; Chang WY
    Health Policy; 2007 Jul; 82(2):251-62. PubMed ID: 17084480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The value of dementia care towards the end of life-A contingent valuation study.
    Bhattarai N; Mason H; Kernohan A; Poole M; Bamford C; Robinson L; Vale L
    Int J Geriatr Psychiatry; 2020 May; 35(5):489-497. PubMed ID: 31912572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Health care contingent valuation studies: a review and classification of the literature.
    Diener A; O'Brien B; Gafni A
    Health Econ; 1998 Jun; 7(4):313-26. PubMed ID: 9683092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
    Nielsen JS; Gyrd-Hansen D; Kjaer T
    Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of factors affecting willingness to pay for cardiovascular disease-related medical services.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Int Heart J; 2006 Mar; 47(2):273-86. PubMed ID: 16607054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contingent Valuation Analysis of an Otolaryngology and Ophthalmology Emergency Department: The Value of Acute Specialty Care.
    Naunheim MR; Kozin ED; Sethi RK; Ota HG; Gray ST; Shrime MG
    JAMA Otolaryngol Head Neck Surg; 2017 Mar; 143(3):234-238. PubMed ID: 27893070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GET MORE, PAY MORE? An elaborate test of construct validity of willingness to pay per QALY estimates obtained through contingent valuation.
    Bobinac A; van Exel NJ; Rutten FF; Brouwer WB
    J Health Econ; 2012 Jan; 31(1):158-68. PubMed ID: 22018622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.